ENTRY       D09901                      Drug
NAME        Etrolizumab (USAN/INN)
FORMULA     C6396H9874N1702O2010S42
EXACT_MASS  144029.1017
MOL_WEIGHT  144117.7642
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFFIT NNYWGWVRQA PGKGLEWVGY ISYSGSTSYN
            PSLKSRFTIS RDTSKNTFYL QMNSLRAEDT AVYYCARTGS SGYFDFWGQG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASESVD DLLHWYQQKP GKAPKLLIKY ASQSISGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ GNSLPNTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H144-H200, H261-H321, H367-H425, H226-H'226, H229-H'229, L23-L88, L134-L194, H220-L214)
  TYPE      Peptide
EFFICACY    Anti-inflammatory
  TYPE      Monoclonal antibody
COMMENT     Treatment of inflammatory bowel disease
TARGET      ITGB7 [HSA:3695] [KO:K06590]
  PATHWAY   hsa04672(3695)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: other families
               Integrins
                ITGB7
                 D09901  Etrolizumab (USAN/INN)
DBLINKS     CAS: 1044758-60-2
            PubChem: 124490613
///
